The Effect of Eukaryotic Expression Plasmid ARHI on Gastric Cancer

LI Li-bo, TANG Qiu-lin, LI Ming-xing, LENG Wei-bing, CHEN Liu, YUAN Dan-dan, LI Rong-hui, BI Feng

Abstract

To study the effect of expressed aplasia ras homolog member I (ARHI) on the malignant biological behaviors of gastric cancer including the proliferation, migration and invasion of the cell. Methods The eukaryotic expression plasmid of ARHI was constructed and transfected into MKN-28 cell with lipofectamineTM2000 as pEGFP-ARHI group, transfected with pEGFP-N1 as pEGFP-N1 group, and untreated MKN-28 as control group. The expression of ARHI was detected by Western blotting and fluorescence microscope. CCK-8 assay was used to analyze the cell proliferation, the wound-healing assay and transwell assay were performed to investigate the effects on migration and invasion. Results Compared with the pEGFP-N1 group and control group, proliferation, invasion and migration of the pEGFP-ARHI group were depressed (P<0.05). Conclusion Recombination eukaryotic expression pEGFP-ARHI could partially reverse the malignant phenotypes of gastric cancer cell MKN-28.

 

Keywords: Aplasia ras homolog member I, MKN-28, Proliferation,Migration, Invasion

 

Full Text:

PDF


References


Maass N. Teffner M. Rosel F. el al. Decline in the expression of the serpin proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast. J Pathol, 2001; 195(3): 321-326.

Sood AK. Fletcher MS. Gruman LM, et al. The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res, 2002;8(9):2924-2932.

Zou Z, Gao C, Nagaich AK, el al. P53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem, 2000;275(9):6051-6054.

Futscher BW, Oshiro MM, Wozniak RJ, el at. Role for DNA methylation in the control of cell type specific maspin expression. Nat Genet,2002;31 (2); 175-179.

Kim S, Han J . Kim J ,el al. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression. Cancer Res.2004 ;64(1) ;6900-6905.

Zhang M. Magit D.Sager R. Expression of maspin in prostate cells is regulated by a positive Ets element and a negative hormonal responsive element site recognized by androgen receptor. Proc Natl Acad Sci U S A, 1997;94(11) ;5673-5678.

Sato N. Fukushima N. Matsubayashi H. et al. Identification of maspin and SI OOP as novel hypomethylation targets in pancreatic cancer using global gene expression profiling. Oncogene,2004;23(8):1531-1538.

Oshiro MM. Watts GS, Wozniak RJ, el al. Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression. Oncogene, 2003; 22(23); 3624-3634.

Umekita Y, Obi Y, Souda M, el al. Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer. Diagn Pathol,2011 ;6:36.

Yang A, Kaghad M, Wang Y, el al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell. 1998;2(3):305-316.

Dohn M, Zhang S, Chen X. p63alpha and dehaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene,2001;20(25) :3193-3205.

Naylor LH. Reporter gene technology: the futhre looks bright. Biochem Pharmacol, 1999;58(5);749-757.

Erchuck A, Robert С. P53 based gene therapy of ovarian cancer magic bullet. J Gynecol Oncol, 1995;59(2) ; 169-171.

De Laurenzi V, Melino G. Evolution of funotions within the p53/p63/p73 family. Ann N Y Acad Sci, 2000; 926 ( 12 ); 90- 100.

Yu YH, Xu F. Peng HQ. el al. NEOY2 ( ARHI ), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci,1999 ; 96(1); 211-219.

Feng WW. Marquez R. Lu Z, et al. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer, 2008; 112 (7):1489-1502.

Luo RZ, Fang XJ, Marquez R. et al. ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers. Cancer Res, 2005; 65 (15):6701-6710.

Dalai I, Missiaglia E. Barbi S. et al. Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors. Neoplasia.2007;9С3): 181-183.

Yang H, Lu XQ, Qian JM, et al. Imprinted tumor suppressor gene ARHI induces apoptosis correlated with changes in DNA methylation in pancreatic cancer cells. Mol Med Report,2010;3 (4):581-587.

Huang J, Lin Y, Li LH. elal. ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis. Mol Carcinog.2009;48(2):130-140.

Badgwell DB, Lu Z, Le K. et al. The tumor-suppressor gene ARHI suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways. Oncogene, 2012; 31 (1): 68-79.

Bao JJ, Le XF, Yuan J, et al. Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway. Cancer Res,2002;62(24); 7261-7272.


Refbacks

  • There are currently no refbacks.